Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives

There is growing recognition that the current research-and-development (R&D) and innovation-regulation ecosystem could be made more efficient to stimulate and support access to innovative therapies for those patients with rare, life-threatening diseases for which there are no adequate licensed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Uguen, David, Lönngren, Thomas, Le Cam, Yann, Garner, Sarah, Voisin, Emmanuelle, Incerti, Carlo, Dunoyer, Marc, Slaoui, Moncef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923002/
https://www.ncbi.nlm.nih.gov/pubmed/24513034
http://dx.doi.org/10.1186/1750-1172-9-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923002/
https://www.ncbi.nlm.nih.gov/pubmed/24513034
http://dx.doi.org/10.1186/1750-1172-9-20

Ejemplares similares